Fermenta Biotech Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	-	316.95	282.4	218.29	352.91	130.56
Short-Term Investments	-	10.64	424.2	379.95	247.68	126.37
Cash & Short-Term Investments	327.58	327.58	706.59	598.24	600.59	256.93
Cash Growth	-53.64%	-53.64%	18.11%	-0.39%	133.75%	-29.35%
Accounts Receivable	-	1,172	1,041	729.75	448.69	870.9
Other Receivables	-	533.1	153.18	9.39	3.51	79.03
Receivables	-	1,706	1,205	785.78	462.45	950.08
Inventory	-	1,614	1,329	890.75	1,312	1,733
Prepaid Expenses	-	41.76	23.27	51.7	26.77	27.85
Restricted Cash	-	78.32	-	0	3.84	0.13
Other Current Assets	-	112.24	88.96	91.07	125.02	172.01
Total Current Assets	-	3,880	3,352	2,418	2,530	3,140
Property, Plant & Equipment	-	2,233	2,322	2,535	2,585	2,373
Long-Term Investments	-	4.3	4.86	4.43	3.76	48.93
Goodwill	-	41.17	41.17	41.17	115.3	109.55
Other Intangible Assets	-	26.17	29.98	71.55	132.72	175.95
Long-Term Deferred Tax Assets	-	183.59	286.44	219.99	332.58	359.94
Long-Term Deferred Charges	-	0.49	0.82	1.15	-	0.16
Other Long-Term Assets	-	98.48	105.38	184.8	664.14	860.34
Total Assets	-	6,479	6,145	5,478	6,365	7,068

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Accounts Payable	-	771.5	774.87	649.04	457.95	645.8
Accrued Expenses	-	60.75	49.94	81.86	40	68.96
Short-Term Debt	-	914.97	812.4	673.42	1,015	974.75
Current Portion of Long-Term Debt	-	94.89	131.13	223.93	318	239.88
Current Portion of Leases	-	12.63	10.92	9.58	6.87	10.7
Current Income Taxes Payable	-	18.43	44.11	3.41	3.25	3.2
Current Unearned Revenue	-	17.3	190.09	3	0.95	-
Other Current Liabilities	-	197.27	105.31	88.36	245.6	127.94
Total Current Liabilities	-	2,088	2,119	1,733	2,087	2,071
Long-Term Debt	-	78.99	150.48	425.36	835.89	1,147
Long-Term Leases	-	31.81	44.44	55.39	19.91	19.68
Pension & Post-Retirement Benefits	-	66.19	41.38	25.62	21.43	18.85
Other Long-Term Liabilities	-	209.2	204.54	387.7	275.1	97.32
Total Liabilities	-	2,474	2,560	2,627	3,240	3,354

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Common Stock	-	143.35	145.85	144.37	144.29	144.24
Additional Paid-In Capital	-	171.62	171.23	23.69	15.28	-
Retained Earnings	-	4,276	3,628	2,903	3,169	3,618
Treasury Stock	-	-170.32	-	-	-	-
Comprehensive Income & Other	-	-358.09	-318.36	-182.93	-174.98	-41.28
Total Common Equity	4,062	4,062	3,627	2,889	3,153	3,721
Minority Interest	-	-56.68	-41.57	-36.98	-27.49	-6.83
Shareholders' Equity	4,005	4,005	3,585	2,852	3,126	3,715
Total Liabilities & Equity	-	6,479	6,145	5,478	6,365	7,068

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Total Debt	1,133	1,133	1,149	1,388	2,195	2,392
Net Cash (Debt)	-805.71	-805.71	-442.76	-789.44	-1,595	-2,135
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-27.54	-27.52	-15.18	-27.34	-55.26	-73.61
Filing Date Shares Outstanding	28.64	28.67	29.43	29.43	28.86	28.85
Total Common Shares Outstanding	28.64	28.67	29.43	29.43	28.86	28.85
Working Capital	-	1,792	1,234	684.93	443.05	1,069
Book Value Per Share	141.68	141.68	123.23	98.15	109.27	129.00
Tangible Book Value	3,995	3,995	3,556	2,776	2,905	3,436
Tangible Book Value Per Share	139.33	139.33	120.81	94.32	100.67	119.10
Land	-	3.43	3.43	3.43	3.43	3.43
Buildings	-	1,065	1,010	1,007	717.57	701.21
Machinery	-	2,221	2,140	2,101	1,892	1,799
Construction In Progress	-	127.9	159.07	16.16	419.03	298.93
Leasehold Improvements	-	59.13	59.13	211.64	211.64	49.86